Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting the company on a path that could lead to its suspension from U. | Moderna is ...

When limited to only Big Pharma companies, the highest rated were Roche, Gilead and Novartis. The steady decline in reputation follows a brief window in which the industry enjoyed positive sentiment ...

Despite President Donald Trump’s threat last week that tariffs on pharmaceuticals will come “very shortly,” the biopharma industry may have a brief reprieve after all—that’s if a new ...

President Donald Trump previewed on Tuesday evening that the pharmaceutical industry will be the next ... They would have stayed here." Get a brief on the top business stories of the week, plus ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for ...

The problem of mistakes in manual invoicing in the pharmaceutical industry is especially prevalent ... business controls which create a reliable audit trail between an invoice and a supply ...

India’s pharmaceutical industry, valued at around $50 billion ... but also noted certain gaps in compliance and audit readiness for regulated markets. “The gap is narrowing.

Federal enforcers did not discuss many specific policies, but stressed they would continue rigorous oversight of the pharmaceutical industry ... also filed an amicus brief in a private case ...

BRUSSELS — After hitting just about every other industry he can think of (albeit with a brief pause), Donald Trump’s long-promised ... in the U.S. because it’s such a big market for pharma, and due to ...

Mr. McInerney brings over 30 years of industry experience spanning senior executive, finance and capital advisory roles in the pharmaceutical and biotechnology sectors Silence Therapeutics plc, Nasdaq ...

Though pharmaceuticals have been exempt from the tariffs announced until now, leaders in the drug industry have ... In his brief remarks on the pharmaceutical tariffs, Trump zeroed in particularly ...